Assessment of the long-term results of the use of metal stents and biodegradable stent platform in patients with ischemic heart disease
DOI:
https://doi.org/10.11603/2414-4533.2023.1.13815Keywords:
biodegradable stent platform, metal stents, coronary heart diseaseAbstract
The aim of the work: to evaluate the long-term results of the use of Absorb biodegradable stent-platform in comparison with the use of metal stents in patients with coronary heart disease.
Materials and Methods. The data of two groups of patients with coronary heart disease who were treated at the clinic of the National Institute of Surgery and Transplantology named after O. O. Shalimov and underwent coronary artery stenting using the biodegradable stent platform (BDSP) Absorb (main group n=70) and metal stents (comparison group n=159) were studied in the period from 2012 to 2015.
Analysis of long-term results was carried out after 4–5 years (2018) and 7–8 years (2021). A positive result was considered the absence of major adverse cardiovascular events after stenting and the need for repeated revascularization. Evaluation of the results was carried out by analyzing electrocardiograms, ultrasound examination of the heart and catamnestic examination.
Results and Discussion. In both observation periods of 2012/13 and 2014/15, 4–5 years after BDSP, a positive result was noted in more than 75 % of patients. While after 2021 (7–8 years) this indicator decreased slightly, but remained at the level of 50 % of patients in whom no cardiovascular events were registered during this period. The indicated data confirm the claims of many studies regarding the sufficient effectiveness of the indicated system in the treatment of coronary occlusions.
References
Ali, Z.A., Gao, R., Kimura, T., Onuma, Y., Kereiakes, D.J., Ellis, S.G., ... & Stone, G.W. (2018). Three-year outcomes with the absorb bioresorbable scaffold: individual-patient-data meta-analysis from the ABSORB randomized trials. Circulation, 137 (5), 464-479. DOI: https://doi.org/10.1161/CIRCULATIONAHA.117.031843
Cerrato, E., Barbero, U., Gil Romero, J. A., Quadri, G., Mejia-Renteria, H., Tomassini, F., ... & Escaned, J. (2019). Magmaris™ resorbable magnesium scaffold: state-of-art review. Future Cardiology, 15 (04), 267-279. DOI: https://doi.org/10.2217/fca-2018-0081
Costantini, C.R., Tarbine, S.G., Costantini, C.O., Shibata, V., Denk, M., & Macedo, R. (2022). Five years clinical outcomes after implantation of Absorb bioresorbable vascular scaffold pilot study in a single center with real world patients, with pre scaffold treatment and guided by intravascular imaging. Journal of the Society for Cardiovascular Angiography & Interventions, 1(5). DOI: https://doi.org/10.1016/j.jscai.2022.100462
Džavík, V., & Colombo, A. (2014). The absorb bioresorbable vascular scaffold in coronary bifurcations: insights from bench testing. JACC: Cardiovascular Interventions, 7 (1), 81-88. DOI: https://doi.org/10.1016/j.jcin.2013.07.013
Jackson-Smith, E., Zioupos, S., & Banerjee, P. (2022). Bioresorbable vascular scaffolds versus conventional drug-eluting stents across time: a meta-analysis of randomised controlled trials. Open Heart, 9 (2), e002107. DOI: https://doi.org/10.1136/openhrt-2022-002107
Landolff, Q., Lefèvre, T., Fajadet, J., Sainsous, J., Lhermusier, T., Elhadad, S., ... & Koning, R. (2022). Five-year clinical outcomes using the bioresorbable vascular scaffold: Insights from the FRANCE ABSORB registry. Archives of Cardiovascular Diseases, 115(10), 505-513. DOI: https://doi.org/10.1016/j.acvd.2022.05.008
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2023 .
This work is licensed under a Creative Commons Attribution 4.0 International License.
Authors who publish their work in Hospital Surgery. Journal by L. Ya. Kovalchuk agree to the following terms:
- Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.
- Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.
- Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work (See The Effect of Open Access)
